Nasdaq Markets

Key PointsOracle's rising bond yields have raised concerns about how the AI build-out will be financed moving forward.

(RTTNews) - A strong positive sentiment is expected to prevail in European stock markets on Wednesday amidst a sharp decline in Fed rate hike expectations. The decline in crude oil prices, the easing in bond yields and the dollar's retreat are also expected to bolster sentiment.

(RTTNews) - TomTom N.V. (TOM2.AS), a location technology specialist, Wednesday announced its expanded collaboration with major global technology company, Microsoft (MSFT), bringing TomTom's location intelligence to AI agents built on Microsoft Fabric and Microsoft Foundry through

(RTTNews) - AbbVie (ABBV) reported positive results from the Phase 2 APEX Part B study of zumilokibart, in adults with moderate to severe atopic dermatitis.

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK,4502.T) announced new data from three Phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279) in adults with moderate-to-severe plaque psoriasis.

(RTTNews) - Galderma (GALD) reported new three-year data from the ARCADIA long-term extension study showing that Nemluvio (nemolizumab) was associated with sustained improvements in skin lesions, itch, sleep disturbance and quality of life in adults and adolescents with moderate-

Key PointsOracle spent $28.5 billion on capital expenditures last quarter, far more than its $19.3 billion in revenue.

(RTTNews) - The Walt Disney Company (DIS) is eliminating hundreds of jobs in its human resources and technology functions, Reuters reported, citing a source familiar with the matter.

(RTTNews) - Huntington Ingalls Industries, Inc. (HII), a military shipbuilder, Tuesday announced that its Newport News Shipbuilding division has secured a $5.09 billion contract for the refueling and complex overhaul or RCOH of nuclear-powered aircraft carrier USS Harry S. Truman

(RTTNews) - Mayne Pharma Group Limited (MYX.AX) has reached settlement with Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), resolving the Paragraph 1V patent litigation concerning IMVEXXY (estradiol vaginal inserts) and its U.S. FDA Orange Book-listed patents.

(RTTNews) - Eli Lilly and Company (LLY) reported detailed Phase 3 TRIUMPH-2 results showing that Retatrutide delivered substantial weight loss and blood sugar reductions in adults with obesity or overweight and type 2 diabetes.

Key PointsThe transaction involved 3,300 shares executed at a weighted average price of $296.58, totaling ~$979,000.

AT&T (NYSE: T) and Verizon (NYSE: VZ) pay attractive dividends, which are catching the attention of passive income investors.

The rising cost of living is putting consumer balance sheets under pressure, which is increasing the risk that people will default on their loans.

A business with a moat becomes an increasingly attractive stock when considering investing for the very long term.

AT&T (NYSE: T) is not going to double your money overnight, but it has the potential to deliver reasonable shareholder returns in the long run.

Duolingo (NASDAQ: DUOL) is prioritizing customer growth over monetization.

Sales are growing for these two semiconductor companies as demand for AI booms.

The healthcare industry is being overlooked by investors who are primarily focused on artificial intelligence.

Starbucks (NASDAQ: SBUX) is closing 250 stores, which has significant implications for investors.